Syneron Medical Receives FDA Clearance for Abdominal Circumferential Reduction and CE mark for the New VelaShape® III Platform (via PR Newswire)
Download image Download image Syneron Medical Ltd logo IRVINE, California, September 10, 2013 /PRNewswire/ — In a clinical study of forty-two patients, an average abdominal circumference reduction of 2.6 cm was achieved following a single VelaShape…
published: September 11, 2013 in: Approval/Clearance, Plastic/Reconstructive